EXCLUSIVE: A young child has become the first in Australia to receive pioneering gene therapy for deafness in a groundbreaking...
Read moreDetailsMelbourne ENT surgeon Professor Stephen O’Leary has revealed encouraging results from a trial of cochlear implant patients who received drug...
Read moreDetailsOver the past 33 years, the Melbourne-based Passe & Williams Foundation has funded more than 400 research projects in Australia...
Read moreDetailsAmerica’s Food and Drug Administration (FDA) has approved a clinical trial of Envoy Medical’s Acclaim fully implanted cochlear implant, the...
Read moreDetailsThe links between hearing impairment, cognitive decline and dementia are receiving much attention as studies point to an association. Other...
Read moreDetailsEar Science Institute Australia is developing a world-first prosthetic eardrum based on silk fibroin biomaterial using silk spun from silkworms...
Read moreDetailsResearchers at the Bionics Institute in Melbourne have developed a world first test to objectively measure tinnitus with a brain...
Read moreDetailsResearchers have documented significant improvements in children and young adults with autism spectrum disorder (ASD) who underwent a short course...
Read moreDetailsA novel drug delivery system may prevent hearing damage during cancer treatment by transporting medications to the inner ear which...
Read moreDetailsNeuromod Devices is planning to make its Lenire device available in Australia and would partner with audiologists and ENTs experienced...
Read moreDetails
Hearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited